A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

Part of paid clinical trials in Houston, Texas.

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study ID
NCT04677998
Status
Recruiting
Apply to this trial

Conditions

  • Familial Adenomatous Polyposis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Personalized surveillance and intervention protocol — PROCEDURE
    This study uses one arm. Participants will undergo endoscopic surveillance with intervals between 3-6 months and 5 years, depending on severity of polyposis and performed endoscopic interventions.

Study Details

The purpose of this study is to determine the efficacy and safety of a personalized surveillance and intervention protocol for duodenal and gastric polyposis in patients with familial adenomatous polyposis (FAP)

Key Dates

Start date
Nov 24, 2020
Status verified
Aug 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Personalized surveillance and intervention protocol

Primary Outcome Measure

Advanced neoplasia [ Time Frame: Up to 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
MD AndersonHoustonTexas77030
Annie Lincoln
[email protected]
+1 919 923 4430
Luigi Ricciardiello (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson· Houston, TX

Related Studies